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Viable mice produced from three-factor induced pluripo-
tent stem (iPS) cells through tetraploid complementation
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Dear Editor,
Ectopic expression of four transcription factors, 
including Oct4, Sox2, Klf4 and c-Myc, in differentiated 
ﬁbroblast cells could reset the cell fate of ﬁbroblast cells 
to pluripotent state [1]. Subsequently, full pluripotency 
of these so-called induced pluripotent stem cells 
(iPSCs) has been demonstrated, as viable mice could be 
generated autonomously from iPSCs through tetraploid 
blastocyst complementation [2, 3]. Moreover, the 
generation of human and patient-specific iPSCs has 
raised the possibility of utilizing iPSCs clinically [4-6]. 
However, the utilization of c-Myc in iPSC induction 
greatly increased the incidence of tumorigenecity 
in the iPS-chimeric mice and also might hinder the 
clinical application of human iPSCs in the future [7]. 
Fortunately, c-Myc has been recently found dispensable 
for iPSC induction even though the induction efﬁciency 
is greatly reduced in the absence of c-Myc [7]. However, 
it remains unknown whether these three factor-induced 
iPSCs are fully pluripotent. In the present study, we 
have successfully demonstrated that three-factor iPSCs 
could also be fully pluripotent, as viable mice could 
be generated from three-factor iPSCs autonomously 
via tetraploid complementation and moreover, our data 
indicate that the pluripotency regulatory mechanism in 
three-factor iPSCs might be distinct from four-factor 
iPSCs.
As previous described, we used Tet-on-inducible len-
tiviruses to transduce cDNAs of the three transcription 
factors Oct4, Sox2 and Klf4 into mouse embryonic ﬁbro-
blast (MEF) cells to generate three-factor iPSCs [8, 9]. 
The MEF cells were collected from the 13.5 d.p.c. em-
bryos, which were generated by mating the OG2 (Oct4-
GFP transgenic) mice with ROSA26-M2rtTA transgenic 
mice. After lentiviral infection, the MEF cells were 
cultured for 3 weeks in ES culture medium supplemented 
with doxycycline, subsequently, GFP-positive colonies 
appeared and then the doxycycline was withdrawn from 
the culture medium. After 3 days, ES-like colonies were 
picked and propagated individually (Figure 1A). In total, 
eight three-factor iPS cell lines were successfully estab-
lished and further characterized. All cell lines exhibited 
morphology resembling normal ES cell lines with Oct4 
expression demonstrated by GFP reporter (Figure 1A) 
and with normal karyotype (Supplementary informa-
tion, Figure S1). RT-PCR and qPCR analysis further 
demonstrated that the expression of pluripotency marker 
genes in three-factor iPS cell lines appeared comparable 
to normal ES cell lines, but showed dramatic differ-
ences from the MEF cells (Figure 1B and Supplementary 
information, Figure S2). Immunofluorescent staining 
results further showed that these three-factor iPSCs 
positively expressed pluripotency transcription factors 
OCT4, NANOG and the ES cell surface marker SSEA1 
(Figure 1C). Bisulphite genomic sequencing was further 
performed to analyze the methylation status of the Oct4 
and Nanog promoters in the three-factor iPSCs, and the 
results conﬁrmed that DNA demethylation occurred dur-
ing the reprogramming process (Figure 1D). Genomic 
PCR for the exogenous factors further conﬁrmed the in-
sertion of the three transgenes in the genome without the 
transgenic c-Myc (Supplementary information, Figure 
S3). Taken together, the iPS cell lines derived using three 
transcription factors were similar to ES cells at the mo-
lecular level.
To further evaluate the functional pluripotency of the 
three-factor iPS cell lines, in vivo differentiation into 
teratomas and tetraploid blastocyst complementation 
assay were performed. The three-factor iPSCs were 
subcutaneously transplanted into immune-deficient 
SCID mice, and the formation of teratomas containing 
derivatives of all three germ layers could be observed 
4 weeks after transplantation (Figure 1E). Tetraploid 
complementation assay was further performed to exam-
ine whether the three-factor iPSCs could capture the full 
pluripotency as observed in four-factor iPSCs. Genera-
tion of tetraploid blastocysts was essentially described in 
our recent study. Microinjection of 10 to 15 three-factor 
iPSCs into each tetraploid blastocyst was performed 
using a Piezo-drill micromanipulator. Subsequently, the 
tetraploid complemented embryos were transplanted into Fully pluripotency of three-factor iPS cells
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either oviduct or uterus of a pseudo-pregnant female ICR 
mouse. Development of the tetraploid complemented 
embryos into live embryos was observed by visualizing 
the Oct4-GFP expression in the genital ridges of an 
E13.5 embryo (Supplementary information, Figure 
S4). Moreover, viable full-term mice were successfully 
obtained from two three-factor iPS cell lines, namely 
LiPS-45 and LiPS-57, through this most rigorous test 
(Supplementary information, Figure S5). Furthermore, 
the mouse (named “little tiger”, which was born on 
Chinese New Year) produced from LiPS-45 grows into 
adulthood and its germline transmission ability was 
further verified by crossing with ICR female mouse 
(Figure 1F). The genotyping of transgene rtta and simple 
sequence length polymorphism (SSLP) analysis further 
confirmed the identity of the three-factor iPS mouse. 
It showed the same background as the donor iPSCs, 
which contain C57BL/6J genetic background with rtta 
insertion rather than the recipient embryos, which were 
B6D2F2 with C57BL/6J and DBA/2 genetic background 
without rtta insertion (Figure 1F). Therefore, for the ﬁrst 
time, we demonstrated that iPSCs reprogrammed by 
three transcription factors in the absence of c-Myc could 
also capture full pluripotency as viable mice could be 
produced through tetraploid complementation. Omission 
of the oncogene c-Myc in reprogramming did not impair 
the property of the derived iPSCs.
It has been recently proposed that the imprinted 
Dlk1 cluster genes play crucial roles in determining 
the pluripotency of iPSCs reprogrammed by four 
transcription factors. Recent findings indicated that 
expression level of Dlk1 cluster genes in the iPS cell 
lines with full pluripotency was similar to ES cells, 
whereas the expression level of the cluster genes in the 
other iPS cell lines with inferior pluripotency was always 
significantly lower [10]. We next sought to examine 
these genes’ expression in our four-factor iPS cell lines 
Figure 1 Generation and characterization of the three-factor iPSCs. (A) Three-factor-derived iPSC colonies (upper) and 
stable cell line LiPS-45 (lower) both of which were GFP-positive indicating the OCT4 expression. (B) RT-PCR revealed that 
iPSCs expressed ES cell marker genes. (C) Immunoﬂuorescent staining results demonstrated that iPSCs were positive 
for OCT4, NANOG and SSEA-1. (D) Bisulﬁte genomic sequencing of the promoter regions of Oct4 and Nanog in LiPS-45, 
LiPS-57 and MEF. Open and close circles indicate unmethylated and methylated CpGs, respectively. (E) Teratomas formed 
4 weeks after injection of iPSCs into SCID mice. Tissues of the three germ layers were detected by hematoxylin and eosin 
staining. (F) The mouse derived totally from LiPS-45 developed into adulthood, and showed germline transmission capability. 
Genomic PCR and SSLP were performed to analyze the live adult mouse derived from iPS-tetraploid complementation. 
Transgene rtTA and D2Mit102 were analyzed. (G) Real time-PCR analysis of Gtl2 and Rian expression in the four-factor (upper) 
and three-factor (lower) iPS cell lines. The green and red columns represented the lines with and without full pluripotency, 
respectively (the iPS cell lines with different pluripotency were shown in Supplementary information, Table S1).  (H) Cluster 
comparing among 4n competent and 4n non-competent iPS cell lines. (I) Scatter plots comparing global gene expression 
patterns between 4n competent and 4n non-competent three-factor iPS cell lines, as determined by DNA microarray. Usp26 
showed lower expression in 4n competent three-factor iPS cell lines. (J) Real time-PCR analysis of the Usp26 expression 
level in the three-factor-derived iPS cell lines.
that we previously established as well as the three-
factor iPS cell lines established in the present study. Our 
results showed that the expression level of these genes 
in the four-factor iPSCs was consistent with their ability 
to fulfill the tetraploid embryo complementation assay 
in general, although several exceptions were observed. 
Surprisingly, the expression level of these genes in most 
three-factor iPS cell lines showed no direct correlation 
with their pluripotency. Expression of these genes with 
similar level to ES cells was observed in most three-
factor iPS cell lines (Figure 1G). Therefore, we propose 
that the molecular pluripotency regulatory mechanism 
might differ between four-factor- and three-factor-
induced reprogramming.
To further explore the gene expression differences 
between the three-factor iPS cell lines with and without 
full pluripotency, we analyzed their global gene 
expression proﬁle using microarray analysis, and the ar-
ray data can be found in GEO database as GSE24046. 
Two three-factor iPS cell lines with full pluripotency 
and two lines with limited pluripotency were used for 
microarray analysis. Similar to the four-factor iPS cell 
lines previously reported, no obvious differences in 
global gene expression were distinguished between the 
two groups of cells (Figure 1H), and moreover we did not 
detect any difference in the expression of Dlk1 cluster 
genes between these two groups of cells. Interestingly, 
the deubiquitination enzyme, Usp26, was the only 
differentially expressed gene distinguished between 
these two groups of iPSCs (Figure 1I). Expression level 
of Usp26 in the three-factor iPS cell lines with full 
pluripotency was generally lower as compared with the 
lines without full pluripotency (Figure 1J), but some 
exceptions were also observed. Although the function of 
Usp26 in iPSCs pluripotency regulation remains elusive, 
we presume that the molecular regulatory mechanism 
in determining the pluripotency of three-factor iPSCs Fully pluripotency of three-factor iPS cells
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might be different from four-factor iPSCs. More in-depth 
investigations will be needed to further elucidate the 
mechanism responsible for establishing the pluripotency 
regulatory network in three-factor iPSCs.
In conclusion, our present study demonstrated that 
iPSCs reprogrammed by three transcription factors in 
the absence of c-Myc could fully capture plurpotency 
and generate iPS mice through tetraploid complementa-
tion. Moreover, the pluripotency regulatory mechanism 
determining the pluripotency of three-factor iPSCs might 
differ from four-factor iPSCs.
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